Profiel
Nataskia Lampe worked as an Associate Director of Regulatory Affairs at Lung Biotechnology PBC.
She then worked at AbbVie, Inc. as an Asset Strategy Leader for Neuroscience & Fibrosis from 2018 to 2021.
In 2021, she became the Vice President & Head of Regulatory Affairs at Pieris Pharmaceuticals, Inc. Ms. Lampe received her undergraduate degree from Tulane University School of Medicine and her graduate degree from Thomas Jefferson University.
Eerdere bekende functies van Nataskia Lampe
Bedrijven | Functie | Einde |
---|---|---|
PIERIS PHARMACEUTICALS, INC. | Algemeen Adviseur | 01-08-2022 |
ABBVIE INC. | Corporate Officer/Principal | 01-08-2021 |
Lung Biotechnology PBC
Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Lung Biotechnology PBC develops pharmaceutical products. It specializes in clinical trials, lung perfusion, and XenoLung. The company was founded by Martine Rothblatt and is headquartered in Silver Spring, MD. | Algemeen Adviseur | - |
Opleiding van Nataskia Lampe
Tulane University School of Medicine | Undergraduate Degree |
Thomas Jefferson University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
PIERIS PHARMACEUTICALS, INC. | Health Technology |
ABBVIE INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Lung Biotechnology PBC
Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Lung Biotechnology PBC develops pharmaceutical products. It specializes in clinical trials, lung perfusion, and XenoLung. The company was founded by Martine Rothblatt and is headquartered in Silver Spring, MD. | Health Technology |